21 – 30 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model
(
- Contribution to journal › Article
-
Mark
A51 Genetically altering metabolism by leptin-deficiency affects peripheral disease features in the R6/2 mouse model of huntington´s disease
2018) European Huntington Disease Network conference 2018 In Journal of Neurology, Neurosurgery and Psychiatry 89(Suppl 1). p.18-18(
- Contribution to journal › Published meeting abstract
-
Mark
Effects of dual administration of liraglutide and ghrelin on brain mitochondrial metabolism in the r6/2 mouse
2018) European Huntington Disease Network conference 2018 In Journal of Neurology, Neurosurgery and Psychiatry 89(Suppl 1). p.92-92(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
A Metabolic Study of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
White adipose tissue browning in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin
(
- Contribution to journal › Article
-
Mark
Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial